-
公开(公告)号:US06683060B2
公开(公告)日:2004-01-27
申请号:US10080662
申请日:2002-02-25
申请人: Li-Wei Hsu , Su-Chen Chang , Jeng-Woei Lee , Pang-Hsi Liu , Hui-Ping Lee , Yi-Ching Chen , Chun-Tsun Chen
发明人: Li-Wei Hsu , Su-Chen Chang , Jeng-Woei Lee , Pang-Hsi Liu , Hui-Ping Lee , Yi-Ching Chen , Chun-Tsun Chen
IPC分类号: C08B3700
CPC分类号: A61K31/70 , Y10S930/144
摘要: The invention discloses methods of treatment and prevention for TNF&agr;-related disorders and MMP-related disorders and compounds useful in such treatments. In particular, the invention dislcoses pharmaceutical compositions comprising a compound of the general formula: wherein X is a Zn(II) chelating group and selected from the group consisting of (CH2)nOH, (CH2)nNH2, (CH2)nSH, (CH2)mCOOH, (CH2)mCOOR, (CH2)mCONH2, (CH2)m″CONH—OH, (CH2)m″CONH—R, and (CH2)n′O(PO3)m″(m″+1), wherein n=2, 3, 4, or 5, n′=2 or 3, m=1, 2, 3, or 4, m′=1, 2, 3, 4, 5, or 6, m″=1, 2, 3, and R=—Cm′, H2m′+1 or aryl groups, especially 1-[3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl]pyrimidine-2,4(1H,3H)-dione, which has an inhibitory effect on matrix metalloproteinase-2 (gelatinase A) and on the binding of TNF&agr; to TNF&agr;-RI.
摘要翻译: 本发明公开了治疗和预防TNFalpha相关病症和MMP相关病症和可用于此类治疗的化合物的方法。 特别地,本发明包含药物组合物,其包含以下通式的化合物:其中X为Zn(II)螯合基团,选自(CH 2)n OH,(CH 2)n NH 2,(CH 2)n SH,(CH 2) )mCOOH,(CH 2)m COOR,(CH 2)m CONH 2,(CH 2)m'CONH-OH,(CH 2)m'CONH-R和(CH 2)n'O(PO 3)m“ '+1)>其中n = 2,3,4或5,n'= 2或3,m = 1,2,3或4,m'= 1,2,3,4,5或 6,m“= 1,2,3和R = -Cm',H2m + 1或芳基,特别是1- [3,4-二羟基-5-(2-羟乙基) - 四氢呋喃-2-基 ]嘧啶-2,4(1H,3H) - 二酮,其对基质金属蛋白酶-2(明胶酶A)和TNFα与TNFα-结合具有抑制作用。
-
公开(公告)号:US06930097B1
公开(公告)日:2005-08-16
申请号:US10420642
申请日:2003-04-21
申请人: Li-Wei Hsu , Su-Chen Chang , Jeng-Woei Lee , Pang-Hsi Liu , Hui-Ping Lee , Yi-Ching Chen , Chun-Tsun Chen
发明人: Li-Wei Hsu , Su-Chen Chang , Jeng-Woei Lee , Pang-Hsi Liu , Hui-Ping Lee , Yi-Ching Chen , Chun-Tsun Chen
IPC分类号: C12N9/99 , A61K31/70 , A61K31/7072 , A61P31/04 , A61P31/12 , A61P35/00 , A61P43/00 , C07H19/06 , C08B37/00 , A01N43/00 , C07H21/00
CPC分类号: A61K31/70 , Y10S930/144
摘要: A compound of formula 1-[3,4-dihydroxy-5-(2-hydroxyethyl)tetrahydrofuran-2-yl]pryimidine-2,4(1H,3H)-dione has inhibitory effects of matrix metalloproteinase-2 (gelatinase A) enzyme and binding of TNFα to TNFα-RI.
摘要翻译: 式1- [3,4-二羟基-5-(2-羟乙基)四氢呋喃-2-基]哒嗪-2,4(1H,3H) - 二酮的化合物具有基质金属蛋白酶-2(明胶酶A)的抑制作用, 酶和TNFalpha与TNFalpha-RI的结合。
-